The Patent Finder

QR Pharma, Inc.

Also on record
Records under this name other than patents QR Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 8 of 8 · Back to QR Pharma, Inc.

PatentTitleStatus Expires Confidence
US 10,383,851(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,096,926(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,376,238(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,382,893(3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods of treating or preventing neurodegeneration
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,400,075(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,144,798(3AR)-1,3A,8-Trimethyl-1 ,2,3,3A,8,8ahexahydropyrrolo[2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,042,482Methods of Treatment or Prevention of Acute Brain or Nerve Injuries
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,596,621Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis via Administration of Posiphen to Healthy or Sick Humans
Formerly held
In force
 · Medium confidence
In forceMedium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited